1. In Vivo
  2. >>Innovation

Finding A Way To Bring Graphene To Diagnostics

 
• By Barnaby Pickering

UK-based Paragraf is working on a range of diagnostic sensors built using graphene, allowing for faster, more sensitive testing products.  

Network Sphere
A 3d illustration of a graphene tube • Source: Shutterstock

In 2004, graphene was physically produced for the first time at Manchester University by using Sellotape to shear off thin layers of carbon. Its discoverers, Andre Geim and Kostya Novoselov, went on to win a Nobel Prize in physics for their findings in 2010. Since then, claims that electronics, vehicles and medicine will be transformed by the carbon-based material said to be both harder and lighter than steel, highly conductive and incredibly light have been rampant. 

However, expensive to produce reliably, graphene has had little impact on industry to date, and very few graphene products have...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation

More from In Vivo

Rising Leaders 2025: Namrata Saroj On The Importance Of Authenticity In Ophthalmology

 
• By Sushmita Panda

Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.

Johnson & Johnson MedTech: How To Scale Digital Solutions

 
• By Natasha Barrow

J&J's EMEA head of digital solutions, Julia Fishman, talks about the hurdles in scaling digital innovation and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.

Rising Leaders 2025: Emma Hodcroft On Taking Initiative When “Plan A” Falls Short

 
• By Anabel Costa-Ferreira

Emma Hodcroft, co-founder of Pathoplexus and a key Nextstrain contributor, stresses the importance of career flexibility for young scientists. She urges early-stage researchers to embrace curiosity, using her unconventional path as an example of how curiosity can lead to impactful success.